The expanding market for long-acting, injectable bupivacaine gives clinicians multiple, additional anesthetic options. Dr. Kerry Schwarz and Dr. John Schoen both Senior Clinical Managers in the Vizient Center for Pharmacy Practice Excellence, join Gretchen Brummel to discuss a recent Vizient Expert Panel on the topic.

Guest speakers:

Dr. John Schoen, PharmD, BCPS

Moderator:

Show Notes:

[00:50 - 01:40] Kerry’s background

[01:40 - 05:26] What's happening in the long-acting bupivacaine market

[05:27 - 07:00] Why Vizient wants to look at this

[07:01 - 11:36] Details on the expert panel process

[11:37 - 13:07] What evidence Vizient reviews

[13:08 - 14:21] Questions John reviewed in the comparative effectiveness assessment

[14:22 - 16:25] What Kerry assesses in the expert opinion section

[16:26 - 17:08] How these findings can be put into practice

Links | Resources:

Long-acting bupivacaine products: full report (member link)

Long-acting bupivacaine products: panel summary (member link)

Expert panels (member link)

Subscribe Today!

Apple Podcasts

Amazon Podcasts

Google Podcasts

Spotify

Stitcher

Android

RSS Feed